MAZE vs UPST · rev $20.0M vs P/E 74, rev $672.9M
Maze Therapeutics, Inc. Common Stock (MAZE) versus Upstart Holdings Inc (UPST) — a side-by-side from cached financials, not a winner call.
Maze Therapeutics, Inc. Common Stock (MAZE) is a biotechnology company listed on US.
Upstart Holdings Inc (UPST) is a credit services company listed on NASDAQ.
Latest reported MAZE revenue for 2026-06-30 was $20.0M. Net income was -$68.9M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. MAZE currently screens at market cap $525.3M.
Latest reported UPST revenue for 2026-06-30 was $672.9M. Net income was $9.9M. UPST currently screens at market cap $2.92B and trailing P/E 74.3.
MAZE currently screens at market cap $525.3M. UPST currently screens at market cap $2.92B and trailing P/E 74.3.
Not investment advice. Open the MAZE and UPST stock pages for the full models.
Not investment advice.